Huang Jing, Li Xiangming, Coelho-dos-Reis Jordana G A, Zhang Min, Mitchell Robert, Nogueira Raquel Tayar, Tsao Tiffany, Noe Amy R, Ayala Ramses, Sahi Vincent, Gutierrez Gabriel M, Nussenzweig Victor, Wilson James M, Nardin Elizabeth H, Nussenzweig Ruth S, Tsuji Moriya
Aaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY, USA.
Department of Pathology, New York University School of Medicine, New York, NY, USA.
J Immunol Methods. 2015 Dec;427:42-50. doi: 10.1016/j.jim.2015.09.005. Epub 2015 Sep 26.
In this study, we developed human immune system (HIS) mice that possess functional human CD4+ T cells and B cells, named HIS-CD4/B mice. HIS-CD4/B mice were generated by first introducing HLA class II genes, including DR1 and DR4, along with genes encoding various human cytokines and human B cell activation factor (BAFF) to NSG mice by adeno-associated virus serotype 9 (AAV9) vectors, followed by engrafting human hematopoietic stem cells (HSCs). HIS-CD4/B mice, in which the reconstitution of human CD4+ T and B cells resembles to that of humans, produced a significant level of human IgG against Plasmodium falciparum circumsporozoite (PfCS) protein upon immunization. CD4+ T cells in HIS-CD4/B mice, which possess central and effector memory phenotypes like those in humans, are functional, since PfCS protein-specific human CD4+ T cells secreting IFN-γ and IL-2 were detected in immunized HIS-CD4/B mice. Lastly, PfCS protein-immunized HIS-CD4/B mice were protected from in vivo challenge with transgenic P. berghei sporozoites expressing the PfCS protein. The immune sera collected from protected HIS-CD4/B mice reacted against transgenic P. berghei sporozoites expressing the PfCS protein and also inhibited the parasite invasion into hepatocytes in vitro. Taken together, these studies show that our HIS-CD4/B mice could mount protective human anti-malaria immunity, consisting of human IgG and human CD4+ T cell responses both specific for a human malaria antigen.
在本研究中,我们开发了具有功能性人类CD4+ T细胞和B细胞的人类免疫系统(HIS)小鼠,命名为HIS-CD4/B小鼠。通过腺相关病毒血清型9(AAV9)载体首先将包括DR1和DR4在内的HLA II类基因以及编码各种人类细胞因子和人类B细胞激活因子(BAFF)的基因导入NSG小鼠,随后植入人类造血干细胞(HSC),从而培育出HIS-CD4/B小鼠。HIS-CD4/B小鼠中人类CD4+ T细胞和B细胞的重建类似于人类,免疫后产生了显著水平的针对恶性疟原虫环子孢子蛋白(PfCS)的人类IgG。HIS-CD4/B小鼠中的CD4+ T细胞具有与人类相似的中央记忆和效应记忆表型,是有功能的,因为在免疫的HIS-CD4/B小鼠中检测到了分泌IFN-γ和IL-2的PfCS蛋白特异性人类CD4+ T细胞。最后,用PfCS蛋白免疫的HIS-CD4/B小鼠受到保护,免受表达PfCS蛋白的转基因伯氏疟原虫子孢子的体内攻击。从受保护的HIS-CD4/B小鼠收集的免疫血清与表达PfCS蛋白的转基因伯氏疟原虫子孢子发生反应,并且在体外也抑制了寄生虫对肝细胞的侵袭。综上所述,这些研究表明,我们的HIS-CD4/B小鼠可以产生保护性的人类抗疟疾免疫,包括针对人类疟疾抗原的人类IgG和人类CD4+ T细胞反应。